Home NDC 54771-1003-2 NDC 54771-1003-2 - AUREOMYCIN This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 54771-1003
Requested NDC 54771-1003-2
Package NDCs from labels 54771-1003-1, 54771-1003-2
Manufacturer Zoetis Inc.
Effective date 2024-06-06
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Labels# Label, Manufacturer, Effective date table Label Manufacturer Effective date Type Aureomycin ® 100 Granular Zoetis Inc. 2024-06-06 VFD TYPE A MEDICATED ARTICLE ANIMAL DRUG LABEL
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 54771-1003-1 AUREOMYCIN 22.68 kg in 1 BAG GRANULE 22.68 8 54771-1003-2 AUREOMYCIN 907 kg in 1 SUPERSACK GRANULE 907 8
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 54771-1003 AUREOMYCIN (CHLORTETRACYCLINE HYDROCHLORIDE) GRANULE [ZOETIS INC.] 8 2 package rows 20240608_0706637a-1062-48ca-be00-4ef4b1dc37db.zip
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.